Zoetis Inc BRDR Z1TS34
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- R$23.00
- Day Range
- R$23.15–23.25
- 52-Week Range
- R$21.93–49.87
- Bid/Ask
- R$0.00 / R$0.00
- Shares Outstanding
- 6.61B
- Market Cap
- R$153.65B
- Volume/Avg
- 3,964 / 6,498
Key Statistics
- Price/Earnings (Normalized)
- 10.67
- Price/Sales
- 3.18
- Dividend Yield (Trailing)
- 2.03%
- Dividend Yield (Forward)
- 2.05%
- Dividend Payment Schedule
- Mar, Jun, Sep, Dec
- Total Yield
- 14.47%
Company Profile
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 14,500
- Website
- https://www.zoetis.com
Competitors
Valuation
|
Metric
|
Z1TS34
|
MRK
|
SNY
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.67 | 45.36 | 11.38 |
Price/Book Value | 9.42 | 8.57 | 1.33 |
Price/Sales | 3.18 | 5.43 | 1.70 |
Price/Cash Flow | 9.43 | 16.30 | 7.04 |
Price/Earnings
Z1TS34
MRK
SNY
Financial Strength
|
Metric
|
Z1TS34
|
MRK
|
SNY
|
|---|---|---|---|
Quick Ratio | 1.57 | 0.71 | 0.49 |
Current Ratio | 3.08 | 1.32 | 0.99 |
Interest Coverage | 14.29 | 4.28 | 8.05 |
Quick Ratio
Z1TS34
MRK
SNY
Profitability
|
Metric
|
Z1TS34
|
MRK
|
SNY
|
|---|---|---|---|
Return on Assets (Normalized) | 18.78% | 6.27% | 7.96% |
Return on Equity (Normalized) | 70.42% | 16.68% | 14.96% |
Return on Invested Capital (Normalized) | 23.70% | 9.82% | 11.28% |
Return on Assets
Z1TS34
MRK
SNY
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|>&Dk<gYx | LOCK|<p&< | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|S$mr<<c | LOCK|^v?P | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|@&??y!% | LOCK|YT& | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|^Sdb&?r! | LOCK|$m | $31B | |||
| Viatris Inc
VTRS
| LOCK|^Y&?!$^ | LOCK|J>T | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|^#s | LOCK|M&$ | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|!m?V?? | LOCK|^Y | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|C<Tx^!q | LOCK|<^% | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|<M&%&%P | LOCK|w<Yk> | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|B<k$Fd@ | LOCK|$DP | $2B |
United States